Max Neeman expands; ACM adds liver tox testing; and Verum joins Biocom
Outsourcing-pharma.com presents a round-up of developments in the contract research sector with news from Max Neeman, ACM and Verum.de.
Archives for October 14, 2012
News from Cytos, Ablynx and Baxter – People on the move
in-PharmaTechnologist.com presents its weekly round up of the latest movers and shakers in the world of pharmaceuticals, including news from Cytos, Ablynx and Baxter.
Piramal looking for injectables capacity at the right price
Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
Marken recertified as C-TPAT compliant
Trial and sample logistics services firm Marken has been recertified by the US Customs and Border Protection (CBP).
Late-stage work will boost PPD's revs, but costs will hit margins says S&P
Returning demand for late-phase trial services will help PPD grow revenue in 2013 but rising labour costs will impact earnings says S&P.
Indian pharma regulations should not change to suit others, says the Government
Indian regulations should not change to suit Western GMP standards, according to the country’s Deputy Drug Controller.
BASF wants a share of pharma omega-3 market
BASF wants a share of the $1.5bn global market for drug grade omega-3 and expects the plant it is building to start shipping product early next year.